title: The A2143G point mutation of clarithromycin resistance affects Helicobacter pylori eradication.
authors.forename: Vincenzo
authors.initials: V
authors.lastname: De Francesco
authors.forename: Angelo
authors.initials: A
authors.lastname: Zullo
authors.forename: Enzo
authors.initials: E
authors.lastname: Ierardi
authors.forename: Floriana
authors.initials: F
authors.lastname: Giorgio
authors.forename: Federico
authors.initials: F
authors.lastname: Perna
authors.forename: Cesare
authors.initials: C
authors.lastname: Hassan
authors.forename: Carmine
authors.initials: C
authors.lastname: Panella
authors.forename: Dino
authors.initials: D
authors.lastname: Vaira
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D017291:Clarithromycin / Q000494:pharmacology*; D004269:DNA, Bacterial / Q000032:analysis / Q000235:genetics; D024881:Drug Resistance, Bacterial / Q000235:genetics*; D016481:Helicobacter Infections / Q000188:drug therapy* / Q000382:microbiology; D016480:Helicobacter pylori / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D017354:Point Mutation; D016133:Polymerase Chain Reaction / Q000379:methods; D017211:Treatment Failure; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D004269:DNA, Bacterial; D017291:Clarithromycin